25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Panagene Inc
Buy, Hold or Sell?

Let's analyze Panagene together

I guess you are interested in Panagene Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Panagene Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Panagene Inc

I send you an email if I find something interesting about Panagene Inc.

1. Quick Overview

1.1. Quick analysis of Panagene (30 sec.)










1.2. What can you expect buying and holding a share of Panagene? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩1,653.72
Expected worth in 1 year
₩2,302.77
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
₩649.05
Return On Investment
23.3%

For what price can you sell your share?

Current Price per Share
₩2,780.00
Expected price per share
₩2,520 - ₩3,200
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Panagene (5 min.)




Live pricePrice per Share (EOD)
₩2,780.00

2.2. Growth of Panagene (5 min.)




Is Panagene growing?

Current yearPrevious yearGrowGrow %
How rich?$47.4m$22.3m$22.5m50.2%

How much money is Panagene making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m$243.9k-$1.7m-116.4%
Net Profit Margin-83.4%10.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Panagene (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Panagene?

Welcome investor! Panagene's management wants to use your money to grow the business. In return you get a share of Panagene.

First you should know what it really means to hold a share of Panagene. And how you can make/lose money.

Speculation

The Price per Share of Panagene is ₩2,780. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Panagene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Panagene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩1,653.72. Based on the TTM, the Book Value Change Per Share is ₩162.26 per quarter. Based on the YOY, the Book Value Change Per Share is ₩10.81 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Panagene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.060.0%-0.040.0%0.010.0%0.010.0%0.010.0%
Usd Book Value Change Per Share0.090.0%0.110.0%0.010.0%0.050.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.090.0%0.110.0%0.010.0%0.050.0%0.050.0%
Usd Price Per Share2.02-2.77-2.92-2.73-2.73-
Price to Earnings Ratio-8.09--0.18-248.45-82.81-82.81-
Price-to-Total Gains Ratio23.56--32.82--602.43--26.90--26.90-
Price to Book Ratio1.74-2.55-4.20-4.19-4.19-
Price-to-Total Gains Ratio23.56--32.82--602.43--26.90--26.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.946
Number of shares513
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.110.05
Usd Total Gains Per Share0.110.05
Gains per Quarter (513 shares)58.2723.49
Gains per Year (513 shares)233.0793.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1023322309484
204664560188178
306996890282272
409329220376366
50116511550470460
60139813880564554
70163216210658648
80186518540752742
90209820870846836
100233123200940930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%8.04.00.066.7%16.04.00.080.0%16.04.00.080.0%16.08.00.066.7%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%17.03.00.085.0%19.04.01.079.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.020.00.0%0.00.024.00.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%17.03.00.085.0%19.04.01.079.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Panagene Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--122.468162.262-25%10.814+1032%65.413+87%65.413+87%
Book Value Per Share--1653.7241561.063+6%991.837+67%989.045+67%989.045+67%
Current Ratio--2.2442.690-17%17.285-87%16.004-86%16.004-86%
Debt To Asset Ratio--0.3670.334+10%0.088+318%0.133+176%0.133+176%
Debt To Equity Ratio--0.5840.505+16%0.097+504%0.173+237%0.173+237%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--78938833395.000129776829921.250-39%150470611087.500-48%134493294086.250-41%134493294086.250-41%
Eps---89.136-51.977-42%10.846-922%15.811-664%15.811-664%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--8.01011.046-27%11.463-30%10.081-21%10.081-21%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap89340026000.000-32%118326910395.000162141386126.250-27%134130551625.000-12%132244867425.250-11%132244867425.250-11%
Net Profit Margin---1.484-0.834-44%0.105-1519%0.088-1777%0.088-1777%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.5861.255-53%0.903-35%0.629-7%0.629-7%
Pb Ratio1.681-4%1.7452.548-32%4.203-58%4.194-58%4.194-58%
Pe Ratio-7.797+4%-8.092-0.183-98%248.450-103%82.812-110%82.812-110%
Price Per Share2780.000-4%2885.0003953.750-27%4173.750-31%3896.750-26%3896.750-26%
Price To Free Cash Flow Ratio----217.9860%8.414-100%8.706-100%8.706-100%
Price To Total Gains Ratio22.700-4%23.557-32.817+239%-602.425+2657%-26.897+214%-26.897+214%
Quick Ratio---1.870-100%22.083-100%17.035-100%17.035-100%
Return On Assets---0.034-0.022-36%0.010-443%0.027-226%0.027-226%
Return On Equity---0.054-0.033-40%0.011-594%0.028-296%0.028-296%
Total Gains Per Share--122.468162.262-25%10.814+1032%65.413+87%65.413+87%
Usd Book Value--47478683.00044813033.655+6%22312053.022+113%24188414.766+96%24188414.766+96%
Usd Book Value Change Per Share--0.0860.114-25%0.008+1032%0.046+87%0.046+87%
Usd Book Value Per Share--1.1581.093+6%0.694+67%0.692+67%0.692+67%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--55257183.37790843780.945-39%105329427.761-48%94145305.860-41%94145305.860-41%
Usd Eps---0.062-0.036-42%0.008-922%0.011-664%0.011-664%
Usd Free Cash Flow----115064.6580%513004.811-100%904495.036-100%904495.036-100%
Usd Market Cap62538018.200-32%82828837.277113498970.288-27%93891386.138-12%92571407.198-11%92571407.198-11%
Usd Price Per Share1.946-4%2.0202.768-27%2.922-31%2.728-26%2.728-26%
Usd Profit---2559096.400-1492027.327-42%243997.119-1149%291134.717-979%291134.717-979%
Usd Revenue--1724545.9002032191.791-15%2300182.519-25%2378527.182-27%2378527.182-27%
Usd Total Gains Per Share--0.0860.114-25%0.008+1032%0.046+87%0.046+87%
 EOD+2 -5MRQTTM+8 -21YOY+13 -185Y+13 -1810Y+13 -18

3.3 Fundamental Score

Let's check the fundamental score of Panagene Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.797
Price to Book Ratio (EOD)Between0-11.681
Net Profit Margin (MRQ)Greater than0-1.484
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.244
Debt to Asset Ratio (MRQ)Less than10.367
Debt to Equity Ratio (MRQ)Less than10.584
Return on Equity (MRQ)Greater than0.15-0.054
Return on Assets (MRQ)Greater than0.05-0.034
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Panagene Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.406
Ma 20Greater thanMa 502,862.750
Ma 50Greater thanMa 1002,874.800
Ma 100Greater thanMa 2003,140.200
OpenGreater thanClose2,890.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Panagene Inc

Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products. The company was formerly known as Koram Panagene Ltd. and changed its name to Panagene Inc. in January 2009. Panagene Inc. was incorporated in 1976 and is based in Daejeon, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 16:55:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Panagene earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • A Net Profit Margin of -148.4% means that ₩-1.48 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Panagene Inc:

  • The MRQ is -148.4%. The company is making a huge loss. -2
  • The TTM is -83.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-148.4%TTM-83.4%-65.0%
TTM-83.4%YOY10.5%-93.9%
TTM-83.4%5Y8.8%-92.3%
5Y8.8%10Y8.8%0.0%
4.3.1.2. Return on Assets

Shows how efficient Panagene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • -3.4% Return on Assets means that Panagene generated ₩-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Panagene Inc:

  • The MRQ is -3.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.4%TTM-2.2%-1.2%
TTM-2.2%YOY1.0%-3.2%
TTM-2.2%5Y2.7%-4.9%
5Y2.7%10Y2.7%0.0%
4.3.1.3. Return on Equity

Shows how efficient Panagene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • -5.4% Return on Equity means Panagene generated ₩-0.05 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Panagene Inc:

  • The MRQ is -5.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.4%TTM-3.3%-2.1%
TTM-3.3%YOY1.1%-4.4%
TTM-3.3%5Y2.8%-6.0%
5Y2.8%10Y2.8%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Panagene Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Panagene is operating .

  • Measures how much profit Panagene makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Panagene Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Panagene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • An Operation Ratio of 0.59 means that the operating costs are ₩0.59 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Panagene Inc:

  • The MRQ is 0.586. The company is very efficient in keeping operating costs low. +2
  • The TTM is 1.255. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.586TTM1.255-0.668
TTM1.255YOY0.903+0.351
TTM1.2555Y0.629+0.626
5Y0.62910Y0.6290.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Panagene Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Panagene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A Current Ratio of 2.24 means the company has ₩2.24 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Panagene Inc:

  • The MRQ is 2.244. The company is able to pay all its short-term debts. +1
  • The TTM is 2.690. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.244TTM2.690-0.446
TTM2.690YOY17.285-14.595
TTM2.6905Y16.004-13.313
5Y16.00410Y16.0040.000
4.4.3.2. Quick Ratio

Measures if Panagene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Panagene Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.870-1.870
TTM1.870YOY22.083-20.212
TTM1.8705Y17.035-15.164
5Y17.03510Y17.0350.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Panagene Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Panagene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Panagene to Biotechnology & Medical Research industry mean.
  • A Debt to Asset Ratio of 0.37 means that Panagene assets are financed with 36.7% credit (debt) and the remaining percentage (100% - 36.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Panagene Inc:

  • The MRQ is 0.367. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.334. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.367TTM0.334+0.033
TTM0.334YOY0.088+0.246
TTM0.3345Y0.133+0.201
5Y0.13310Y0.1330.000
4.5.4.2. Debt to Equity Ratio

Measures if Panagene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • A Debt to Equity ratio of 58.4% means that company has ₩0.58 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Panagene Inc:

  • The MRQ is 0.584. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.505. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.584TTM0.505+0.079
TTM0.505YOY0.097+0.409
TTM0.5055Y0.173+0.332
5Y0.17310Y0.1730.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Panagene generates.

  • Above 15 is considered overpriced but always compare Panagene to the Biotechnology & Medical Research industry mean.
  • A PE ratio of -8.09 means the investor is paying ₩-8.09 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Panagene Inc:

  • The EOD is -7.797. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.092. Based on the earnings, the company is expensive. -2
  • The TTM is -0.183. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.797MRQ-8.092+0.294
MRQ-8.092TTM-0.183-7.908
TTM-0.183YOY248.450-248.633
TTM-0.1835Y82.812-82.995
5Y82.81210Y82.8120.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Panagene Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-217.986+217.986
TTM-217.986YOY8.414-226.400
TTM-217.9865Y8.706-226.692
5Y8.70610Y8.7060.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Panagene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A PB ratio of 1.74 means the investor is paying ₩1.74 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Panagene Inc:

  • The EOD is 1.681. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.745. Based on the equity, the company is underpriced. +1
  • The TTM is 2.548. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.681MRQ1.745-0.063
MRQ1.745TTM2.548-0.803
TTM2.548YOY4.203-1.655
TTM2.5485Y4.194-1.646
5Y4.19410Y4.1940.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets107,214,767
Total Liabilities39,388,077
Total Stockholder Equity67,474,967
 As reported
Total Liabilities 39,388,077
Total Stockholder Equity+ 67,474,967
Total Assets = 107,214,767

Assets

Total Assets107,214,767
Total Current Assets81,602,393
Long-term Assets25,612,374
Total Current Assets
Total Current Assets  (as reported)81,602,393
Total Current Assets  (calculated)0
+/- 81,602,393
Long-term Assets
Long-term Assets  (as reported)25,612,374
Long-term Assets  (calculated)0
+/- 25,612,374

Liabilities & Shareholders' Equity

Total Current Liabilities36,361,758
Long-term Liabilities3,026,319
Total Stockholder Equity67,474,967
Total Current Liabilities
Total Current Liabilities  (as reported)36,361,758
Total Current Liabilities  (calculated)0
+/- 36,361,758
Long-term Liabilities
Long-term Liabilities  (as reported)3,026,319
Long-term Liabilities  (calculated)0
+/- 3,026,319
Total Stockholder Equity
Total Stockholder Equity (as reported)67,474,967
Total Stockholder Equity (calculated)0
+/- 67,474,967
Other
Common Stock Shares Outstanding 41,015
Net Invested Capital 67,474,967
Net Working Capital 45,240,635



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302013-09-302013-06-302013-03-312012-12-31
> Total Assets 
25,505,336
0
27,923,297
25,874,408
21,765,615
21,786,741
22,232,829
24,672,340
26,078,339
27,231,815
28,670,502
30,640,821
32,221,157
31,909,402
33,565,321
33,987,803
34,561,377
34,673,429
35,686,788
34,881,088
95,862,131
90,913,796
91,542,009
107,214,767
107,214,76791,542,00990,913,79695,862,13134,881,08835,686,78834,673,42934,561,37733,987,80333,565,32131,909,40232,221,15730,640,82128,670,50227,231,81526,078,33924,672,34022,232,82921,786,74121,765,61525,874,40827,923,297025,505,336
   > Total Current Assets 
7,902,711
0
14,591,820
12,275,372
10,024,669
10,114,103
10,616,490
11,872,503
15,913,571
18,567,008
18,984,536
20,937,551
22,588,665
23,444,410
23,692,668
21,729,835
22,218,815
26,013,527
27,038,419
26,667,872
88,021,389
82,900,265
81,496,514
81,602,393
81,602,39381,496,51482,900,26588,021,38926,667,87227,038,41926,013,52722,218,81521,729,83523,692,66823,444,41022,588,66520,937,55118,984,53618,567,00815,913,57111,872,50310,616,49010,114,10310,024,66912,275,37214,591,82007,902,711
       Cash And Cash Equivalents 
1,439,341
0
6,405,471
5,833,533
0
-49,818
-46,690
3,609,581
6,136,712
9,343,404
6,584,000
8,205,537
8,815,643
10,611,264
0
0
0
9,446,980
8,675,247
8,359,242
1,892,285
10,252,049
2,000,647
0
02,000,64710,252,0491,892,2858,359,2428,675,2479,446,98000010,611,2648,815,6438,205,5376,584,0009,343,4046,136,7123,609,581-46,690-49,81805,833,5336,405,47101,439,341
       Short-term Investments 
2,100,000
0
1,040,000
0
0
0
0
0
2,601,324
2,620,002
6,086,747
6,084,997
7,020,000
7,000,000
7,000,000
7,000,000
8,000,000
10,500,000
12,473,400
12,484,600
75,097,000
66,600,000
72,600,000
0
072,600,00066,600,00075,097,00012,484,60012,473,40010,500,0008,000,0007,000,0007,000,0007,000,0007,020,0006,084,9976,086,7472,620,0022,601,324000001,040,00002,100,000
       Net Receivables 
3,479,990
0
2,437,666
1,660,363
3,066,854
2,640,114
3,231,751
2,723,223
3,202,276
3,320,255
2,770,923
2,864,506
3,024,234
2,438,050
3,780,112
3,050,693
2,940,305
2,726,908
2,573,450
2,709,085
2,779,899
2,164,792
2,779,883
0
02,779,8832,164,7922,779,8992,709,0852,573,4502,726,9082,940,3053,050,6933,780,1122,438,0503,024,2342,864,5062,770,9233,320,2553,202,2762,723,2233,231,7512,640,1143,066,8541,660,3632,437,66603,479,990
       Inventory 
713,793
0
485,487
599,324
1,266,715
1,246,794
1,353,812
2,433,264
3,638,481
3,159,320
3,404,371
3,666,741
3,578,062
3,307,011
3,485,692
3,651,434
3,422,465
3,259,345
3,241,512
3,053,279
2,731,855
2,905,960
3,216,794
0
03,216,7942,905,9602,731,8553,053,2793,241,5123,259,3453,422,4653,651,4343,485,6923,307,0113,578,0623,666,7413,404,3713,159,3203,638,4812,433,2641,353,8121,246,7941,266,715599,324485,4870713,793
       Other Current Assets 
169,587
0
4,223,197
4,182,152
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
9,850
0
09,8500000000000000100004,182,1524,223,1970169,587
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,659,901
8,648,369
8,213,216
7,840,742
8,013,531
10,045,495
25,612,374
25,612,37410,045,4958,013,5317,840,7428,213,2168,648,3698,659,90100000000000000000
       Property Plant Equipment 
8,412,660
0
4,263,560
4,198,870
8,627,666
8,437,176
8,193,842
8,043,336
7,979,845
7,725,101
7,651,577
7,639,414
7,419,611
7,298,163
7,328,720
7,160,033
7,047,109
7,028,676
7,057,717
7,039,030
6,940,738
7,337,588
7,159,839
0
07,159,8397,337,5886,940,7387,039,0307,057,7177,028,6767,047,1097,160,0337,328,7207,298,1637,419,6117,639,4147,651,5777,725,1017,979,8458,043,3368,193,8428,437,1768,627,6664,198,8704,263,56008,412,660
       Long Term Investments 
544,580
0
189,272
215,484
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000215,484189,2720544,580
       Intangible Assets 
8,245,263
0
8,544,578
8,838,765
203,532
206,226
197,169
224,206
247,013
259,173
245,648
235,136
295,437
291,390
287,497
276,325
264,956
255,147
246,008
260,596
269,341
286,167
274,878
0
0274,878286,167269,341260,596246,008255,147264,956276,325287,497291,390295,437235,136245,648259,173247,013224,206197,169206,226203,5328,838,7658,544,57808,245,263
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
113,443
0
0113,4430001000000000000000000
> Total Liabilities 
16,582,084
0
15,878,019
14,772,306
1,610,342
1,581,968
1,906,679
2,277,465
2,081,677
2,161,530
2,398,914
2,849,164
2,621,184
2,065,805
2,591,303
3,091,014
2,838,154
2,984,183
3,888,736
2,594,163
33,990,976
27,340,873
28,738,299
39,388,077
39,388,07728,738,29927,340,87333,990,9762,594,1633,888,7362,984,1832,838,1543,091,0142,591,3032,065,8052,621,1842,849,1642,398,9142,161,5302,081,6772,277,4651,906,6791,581,9681,610,34214,772,30615,878,019016,582,084
   > Total Current Liabilities 
4,597,499
0
14,544,573
13,813,013
443,945
488,824
683,105
995,432
705,676
981,672
946,141
1,268,150
948,095
794,423
1,180,368
1,208,336
960,493
1,418,798
1,651,170
2,360,739
33,774,013
27,134,496
28,537,208
36,361,758
36,361,75828,537,20827,134,49633,774,0132,360,7391,651,1701,418,798960,4931,208,3361,180,368794,423948,0951,268,150946,141981,672705,676995,432683,105488,824443,94513,813,01314,544,57304,597,499
       Short-term Debt 
2,584,448
2,584,448
2,310,574
1,281,314
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,281,3142,310,5742,584,4482,584,448
       Short Long Term Debt 
2,584,448
2,584,448
2,310,574
1,281,314
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,643,176
23,017,554
25,070,799
0
025,070,79923,017,55412,643,17600000000000000001,281,3142,310,5742,584,4482,584,448
       Accounts payable 
1,133,051
0
1,034,062
1,070,435
0
0
0
0
0
0
0
0
0
0
0
0
0
216,813
330,284
356,686
83,413
431,646
182,278
0
0182,278431,64683,413356,686330,284216,81300000000000001,070,4351,034,06201,133,051
       Other Current Liabilities 
1,450,000
0
11,579,937
11,461,264
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
986,639
0
0986,63900011000000000000011,461,26411,579,93701,450,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,565,386
2,237,565
233,424
216,963
206,376
201,091
3,026,319
3,026,319201,091206,376216,963233,4242,237,5651,565,38600000000000000000
       Long term Debt Total 
0
0
0
0
24,051
8,267
0
14,015
7,785
11,598
39,260
54,876
60,767
42,880
87,021
80,336
67,551
129,424
141,326
127,641
0
0
0
0
0000127,641141,326129,42467,55180,33687,02142,88060,76754,87639,26011,5987,78514,01508,26724,0510000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
208,019
228,739
219,396
205,775
187,453
176,606
0
0176,606187,453205,775219,396228,739208,01900000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
121,418
0
0121,4180000100000000000000000
> Total Stockholder Equity
8,923,252
8,923,252
12,045,278
11,102,102
20,155,272
20,204,773
20,326,150
22,394,875
23,996,662
25,070,285
26,271,588
27,791,657
29,599,973
29,843,597
30,974,019
30,896,790
31,723,223
31,689,245
31,798,052
32,286,925
61,871,154
63,572,924
62,803,710
67,474,967
67,474,96762,803,71063,572,92461,871,15432,286,92531,798,05231,689,24531,723,22330,896,79030,974,01929,843,59729,599,97327,791,65726,271,58825,070,28523,996,66222,394,87520,326,15020,204,77320,155,27211,102,10212,045,2788,923,2528,923,252
   Common Stock
12,422,941
0
13,403,333
13,403,333
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
16,068,330
0
0
0
0
000016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33016,068,33013,403,33313,403,333012,422,941
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000
   Capital Surplus 
0
0
0
0
64,842,353
64,846,346
64,850,167
64,850,167
64,850,167
64,850,167
64,850,167
64,661,935
64,661,935
64,661,935
64,661,935
64,661,935
64,818,227
64,818,227
64,850,166
64,850,166
0
0
0
0
000064,850,16664,850,16664,818,22764,818,22764,661,93564,661,93564,661,93564,661,93564,661,93564,850,16764,850,16764,850,16764,850,16764,850,16764,846,34664,842,3530000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
4,324,371
4,324,371
4,324,370
4,324,371
4,324,371
4,324,371
4,324,371
4,324,371
4,324,371
4,324,370
4,324,371
4,324,371
4,324,371
4,324,371
4,324,370
4,324,371
0
0
0
0
00004,324,3714,324,3704,324,3714,324,3714,324,3714,324,3714,324,3704,324,3714,324,3714,324,3714,324,3714,324,3714,324,3714,324,3704,324,3714,324,3710000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue12,252,031
Cost of Revenue-4,028,894
Gross Profit8,223,1378,223,137
 
Operating Income (+$)
Gross Profit8,223,137
Operating Expense-14,091,332
Operating Income-1,839,301-5,868,195
 
Operating Expense (+$)
Research Development3,782,271
Selling General Administrative2,202,713
Selling And Marketing Expenses0
Operating Expense14,091,3325,984,984
 
Net Interest Income (+$)
Interest Income1,533,347
Interest Expense-591,591
Other Finance Cost-0
Net Interest Income941,756
 
Pretax Income (+$)
Operating Income-1,839,301
Net Interest Income941,756
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,537,694-1,839,301
EBIT - interestExpense = -591,591
-4,815,636
-4,224,045
Interest Expense591,591
Earnings Before Interest and Taxes (EBIT)0-4,946,103
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-5,537,694
Tax Provision--722,058
Net Income From Continuing Ops-4,815,636-4,815,636
Net Income-4,815,636
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-941,756
 

Technical Analysis of Panagene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Panagene. The general trend of Panagene is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Panagene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Panagene Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3,180 < 3,200 < 3,200.

The bearish price targets are: 2,565 > 2,520.

Tweet this
Panagene Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Panagene Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Panagene Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Panagene Inc. The current macd is -10.37663851.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Panagene price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Panagene. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Panagene price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Panagene Inc Daily Moving Average Convergence/Divergence (MACD) ChartPanagene Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Panagene Inc. The current adx is 18.19.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Panagene shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Panagene Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Panagene Inc. The current sar is 3,203.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Panagene Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Panagene Inc. The current rsi is 44.41. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Panagene Inc Daily Relative Strength Index (RSI) ChartPanagene Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Panagene Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Panagene price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Panagene Inc Daily Stochastic Oscillator ChartPanagene Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Panagene Inc. The current cci is -49.10793146.

Panagene Inc Daily Commodity Channel Index (CCI) ChartPanagene Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Panagene Inc. The current cmo is -15.49561249.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Panagene Inc Daily Chande Momentum Oscillator (CMO) ChartPanagene Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Panagene Inc. The current willr is -53.76344086.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Panagene is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Panagene Inc Daily Williams %R ChartPanagene Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Panagene Inc.

Panagene Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Panagene Inc. The current atr is 156.08.

Panagene Inc Daily Average True Range (ATR) ChartPanagene Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Panagene Inc. The current obv is 47,995,183.

Panagene Inc Daily On-Balance Volume (OBV) ChartPanagene Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Panagene Inc. The current mfi is 45.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Panagene Inc Daily Money Flow Index (MFI) ChartPanagene Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Panagene Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Panagene Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Panagene Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.406
Ma 20Greater thanMa 502,862.750
Ma 50Greater thanMa 1002,874.800
Ma 100Greater thanMa 2003,140.200
OpenGreater thanClose2,890.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Panagene with someone you think should read this too:
  • Are you bullish or bearish on Panagene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Panagene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Panagene Inc

I send you an email if I find something interesting about Panagene Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Panagene Inc.

Receive notifications about Panagene Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.